Results: The predominant species during all periods was Shigella sonnei, with an increasing predominance across the periods (64.0%, 71.5%, and 87.8%, respectively; p < 0.001). Neither the prevalence of bloody diarrhea nor other clinical characteristics changed across the study periods, except for the prevalence of dehydration, which increased (11.0%, 20.6%, and 28.6%, respectively; p < 0.001). During the period [2003] [2004] [2005] [2006] [2007] [2008] [2009] 69 .9% of Shigella were resistant to trimethoprim/sulfamethoxazole, 35.8% to ampicillin, and 4.7% to nalidixic acid. No case resistant to ciprofloxacin was detected. Multidrug resistance was also found to be similar in the last two periods (24.0% vs. 28.1%, respectively). Conclusions: There was both a microbiological and a clinical change in childhood Shigella gastroenteritis cases over the 22 years. The antibiotic resistance pattern appears to have remained stable over the last two periods. There is a need to re-examine the criteria and clinical management guidelines for suspected shigellosis cases. 
Results
Between the years 2003 and 2009, 238 Shigella cases were identified (136 male, 102 female). The overall isolation rate of Shigella sp was 1.6% (238/14 803) during this period. Among the isolates, 209 (87.8%) were S. sonnei, 25 (10.5%) were S. flexneri, and four (1.7%) were S. boydii. The comparative distributions of Shigella sp within the three periods are shown in Figure 1 . During the study period, as in the previous periods, most of the Shigella cases (65.9%; p < 0.001) were identified in the dry and hot season (between July and October).
The clinical characteristics of the cases and comparison with the previous periods are shown in Table 1 . In our study the mean age of the cases was 93 AE 48 months (range 5-202 months). S. flexneri was isolated from younger patients compared with S. sonnei (72.4 AE 68.5 months, 96.9 AE 44.8 months, respectively; p < 0.05), but during the previous period S. sonnei was isolated from younger patients compared with S. flexneri (52.8 AE 39.8 months, 70.2 AE 46.6 months, respectively; p < 0.001). Except for convulsions (p = 0.04), none of the clinical characteristics differed significantly among the different species during the study period (Table 2) .
When the cases were analyzed according to blood in stool, it was found that, although not statistically significant, the Shigella cases who were admitted with bloody diarrhea were older (92.6 AE 43.2 months vs. 90.9 AE 46.6 months; p = 0.85), had a higher daily stool output frequency (8.2 AE 5.5/day vs. 6.9 AE 5.1/day; p = 0.17), and were hospitalized more frequently (6.0% and 1.8%; p = 0. 15 non-bloody diarrhea received antibiotics on admission (p < 0.05).
The most frequently prescribed antibiotic was cefixime (46/62), and there was a sharp increase in the prescription rate of cefixime (16.3% to 74.2%). As in the previous period, ciprofloxacin (6/62) was the second most commonly prescribed antibiotic during the study period; the third was ceftriaxone (3/62). TMP-SMX, the most frequently used antibiotic of the previous periods, was not prescribed for any patient during the years 2003-2009. Only four patients' initial antibiotic therapies (6.6%) were changed to another antibiotic (all were ciprofloxacin) after the results of stool cultures. Antibiotic therapy was initiated in 21 cases after obtaining the results of stool cultures, and among these the most frequently prescribed antibiotic was ciprofloxacin (14/21). The antibiotic resistance patterns as well as multidrug resistance rates of each Shigella species during the study period are displayed in Table 3 . The most common multidrug resistance pattern was to TMP-SMX and ampicillin (58 cases), followed by TMP-SMX and nalidixic acid (6 cases), TMP-SMX, ampicillin, and nalidixic acid (2 cases), and ampicillin and nalidixic acid (1 case). Among the multi-resistant species, 66 (98.5%) were resistant to TMP-SMX, similar to the 1995-2002 period. Comparison of the antibiotic resistance patterns between the three periods is shown in Figure 2 . Multidrug resistance increased for S. sonnei (6.3% to 26.8%; p < 0.001) and decreased for S. flexneri 
Discussion
Between the years 1987 and 1994 the Shigella isolation rate at our center was 3.1%. The isolation rate decreased to 1.6% in the 1995-2002 period and had not changed during the study period (2003-2009). Our isolation rate is lower than others reported in our region; for example in Tehran, Iran between the years 2001 and 2006, the Shigella isolation rate was found to be 4.5%. 17 Before 1987, S. flexneri was the most common Shigella species isolated in Turkey. 18, 19 A similar significant species shift has also been reported in Vietnam and Iran. 10, 17 However, there are some countries from our region still reporting S. flexneri as the predominant species.
20,21
Most endemic shigellosis occurs in children aged between 6 months and 3 years. 3 At our center, while the number of patients under 1 year of age has decreased over the years, the number of patients over 5 years of age has increased. The low isolation rate of Shigella in those under 1 year of age and the shift of cases to older age groups may be due to the protective effect of breastfeeding. Breastfeeding reduces the severity of Shigella infections and shifts the spectrum of Shigella infections from severe to non-severe illness. 22, 23 According to the Turkey Demographic and Health Survey, 2008, 69% of infants are exclusively breastfed in the first 2 months of life. The median duration of breastfeeding for all children is 16 months. 24 However the trends in increased age of cases cannot be explained solely by prolonged breastfeeding. This change could be related to changes in referral to our hospital or to improved hygiene and/or socioeconomic status decreasing the intensity of enteric pathogen transmission in Ankara, Turkey. Values are % of isolates. Figure 2 . Antibiotic resistance patterns during the different study periods(*p < 0.001; N/A: not applicable). The shift of cases to older ages and the predominance of S. sonnei may explain the mild clinical course, low hospitalization rate, and absence of death among our cases. On the other hand, S. flexneri cases were found to be younger and more often had bloody diarrhea, which may be the reason for more frequent antibiotic use and hospitalization. Dehydration seems to be the most important emerging complication in our patients, but oral rehydration therapy appears to be adequate for these cases. However among 238 cases, only 161 files were available for the determination of clinical characteristics. We believe that this may be a drawback of our study in terms of evaluating the clinical characteristics of our patients.
The first choice of antibiotic at our center has changed from TMP-SMX to cefixime. This may be mostly related to the high resistance rate to TMP-SMX. High TMP-SMX resistance rates of between 47.4% and 96.5% are being reported from other regions. 10, 11, 17, 20, 25, 26 18 reported that although they found an overall high ampicillin susceptibility rate, S. flexneri was highly resistant to ampicillin (60.0%). Studies from Pakistan 26 and Vietnam 10 have also reported high species-specific (S. flexneri) resistance rates to ampicillin, which is also the case in our country. On the other hand results from the USA 28 have shown similar high resistance rates for both S. sonnei and S. flexneri. In the 1990s, quinolones emerged as the preferred agents for the treatment of Shigella. Most authorities recommend an oral quinolone for proven or suspected shigellosis. Nalidixic acid and ciprofloxacin are highly effective treatment alternatives, despite reservations about their use in children. However Shigella resistance to ciprofloxacin is increasingly common in India and in travelers returning from India. 29 A recent report from Bangalore, India, described an increase of resistance to ciprofloxacin from 0 to 48% over a 5-year period between 2002 and 2007. 30 On the other hand in both periods of our study there was no Shigella species resistant to ciprofloxacin. Nalidixic acid resistance at our center was found to be only 4.7%, however nalidixic acid is not available in Turkey, so is not prescribed. Multidrug resistance increased slightly at our center between the last two periods. Multidrug resistance was more common among S. flexneri cases. This is also in accordance with other reports. 21, 28 In conclusion, there was a change in the clinical characteristics of childhood Shigella gastroenteritis at our center over the 22 years, mostly related to the species shift. The antibiotic resistance pattern appears to have remained stable over the last two periods. Clinical management guidelines covering the increasing cases of non-dysenteric shigellosis on admission may be helpful in decreasing the transmission of this disease in society.
